Artificial intelligence for diagnosing seborrheic keratosis
Part of Skin clinical trials.
This study tests whether an artificial intelligence program can correctly identify seborrheic keratosis from skin biopsy slides. If successful, it could help doctors diagnose this common skin condition faster and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a skin biopsy sample that was already diagnosed as seborrheic keratosis.
- The biopsy slide is well-stained and preserved, so that features are clearly visible.
- The slide has no damage, fading, or other quality issues.
- The original diagnosis was clear and certain.
- The slide can be digitized (scanned) without technical problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to help diagnose basal cell carcinoma, a common type of skin cancer, from digital images of tissue samples. It may improve accuracy and speed of diagnosis.
This study tests if artificial intelligence can accurately diagnose androgenetic alopecia (common pattern hair loss) using images of the scalp. If you have pattern hair loss, you may help train or validate the AI system.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
This study tests whether artificial intelligence can help doctors see colorectal lesions more clearly using special advanced imaging. If you have a colorectal lesion, this trial may help improve diagnosis.
Hear when a new Artifical Intelligence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.